By Yu Yu
Elagolix is an orally active gonadotropin-releasing hormone antagonist that has just recently completed Phase 3 clinical trial for endometriosis-associated pain (NCT01931670).
The review article by Alessandro et al in Archives of Gynecology and Obstetrics summarized the current research findings on…
Key Points
Lay Summary